Mindera Corporation, a San Diego, CA-based company developing and commercializing next-generation medical technology, raised $12.6M in Series A-2 funding.
The round was led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development.
Mindera is a company developing and commercializing medical technology to enable skin analytics at the molecular level. Using a proprietary dermal biomarker patch, Next-Generation Sequencing (NGS) and Machine Learning, the technology generates clinically validated data to reduce healthcare system costs and improve patient outcomes.
The company intends to use the funds to commercialize Mind.Px, a tool to prospectively predict patient response to expensive psoriasis biologics, as well as continue development of the Mindera Dermal Intelligence™ Platform.
Mindera is a CLIA and ISO 13485 certified Laboratory.